BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32112710)

  • 1. Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant.
    Aziz F; Jorgenson MR; Parajuli S; Zhong W; Hidalgo LG; Djamali A; Mandelbrot D; Odorico J; Sollinger H; Astor BC; Mohamed MA
    Transpl Infect Dis; 2020 Jun; 22(3):e13272. PubMed ID: 32112710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
    Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
    Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation.
    Elfadawy N; Flechner SM; Liu X; Schold J; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
    Transplantation; 2013 Dec; 96(12):1097-103. PubMed ID: 24056621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
    Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
    Westphal SG; Lyden ER; Langewisch ED; Miles CD
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort.
    Pullerits K; Garland S; Rengarajan S; Guiver M; Chinnadurai R; Middleton RJ; Chukwu CA; Kalra PA
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy.
    Reischig T; Kacer M; Hes O; Machova J; Nemcova J; Lysak D; Jindra P; Pivovarcikova K; Kormunda S; Bouda M
    Am J Transplant; 2019 Sep; 19(9):2457-2467. PubMed ID: 31220412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous pancreas/kidney transplant recipients are predisposed to tissue-invasive cytomegalovirus disease and concomitant infectious complications.
    Schachtner T; Zaks M; Otto NM; Kahl A; Reinke P
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28665480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and impact of cytomegalovirus disease in simultaneous pancreas-kidney transplantation.
    Kaufman DB; Leventhal JR; Gallon LG; Parker MA; Koffron AJ; Fryer JP; Abecassis MM; Stuart FP
    Transplantation; 2001 Dec; 72(12):1940-5. PubMed ID: 11773893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.
    Huurman VA; Kalpoe JS; van de Linde P; Vaessen N; Ringers J; Kroes AC; Roep BO; De Fijter JW
    Diabetes Care; 2006 Apr; 29(4):842-7. PubMed ID: 16567825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of cytomegalovirus infection after pancreas transplantation.
    Parsaik AK; Bhalla T; Dong M; Rostambeigi N; Dierkhising RA; Dean P; Abraham R; Prieto M; Kremers WK; Razonable RR; Kudva YC
    Transplantation; 2011 Nov; 92(9):1044-50. PubMed ID: 21904269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center.
    Mindlova M; Boucek P; Saudek F; Skibova J; Jedinakova T; Lipar K; Adamec M; Hirsch HH
    Clin Transplant; 2012; 26(2):267-74. PubMed ID: 21854452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study.
    Los-Arcos I; Len O; Perello M; Torres IB; Codina G; Esperalba J; Sellarés J; Moreso F; Seron D; Gavaldà J
    J Clin Virol; 2019 Jan; 110():45-50. PubMed ID: 30537648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antimetabolite discontinuation following cytomegalovirus or BK polyoma virus infection in kidney transplant recipients.
    Dubrawka CA; Progar KJ; January SE; Hagopian JC; Nesselhauf NM; Malone AF
    Transpl Infect Dis; 2022 Dec; 24(6):e13931. PubMed ID: 35980197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV, CMV, and BK viral infections in pediatric kidney transplantation: Frequency, risk factors, treatment, and outcomes.
    Levi S; Davidovits M; Alfandari H; Dagan A; Borovitz Y; Bilavsky E; Landau D; Haskin O
    Pediatr Transplant; 2022 May; 26(3):e14199. PubMed ID: 34817112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.
    Verghese PS; Schmeling DO; Knight JA; Matas AJ; Balfour HH
    Transplantation; 2015 Mar; 99(3):602-8. PubMed ID: 25148381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
    Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
    Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression.
    Shah AP; Chen JM; Fridell JA
    Clin Transplant; 2015 Dec; 29(12):1221-9. PubMed ID: 26458498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients.
    Humar A; Uknis M; Carlone-Jambor C; Gruessner RW; Dunn DL; Matas A
    Transplantation; 1999 Jan; 67(1):94-7. PubMed ID: 9921803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.